HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Naoko Mori Selected Research

Contrast Media

1/2015Luminal-type breast cancer: correlation of apparent diffusion coefficients with the Ki-67 labeling index.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Naoko Mori Research Topics

Disease

5Rheumatoid Arthritis
01/2022 - 08/2014
4Breast Neoplasms (Breast Cancer)
08/2022 - 01/2012
3Neuroblastoma
07/2011 - 11/2008
2Infections
01/2022 - 08/2005
2Arthritis (Polyarthritis)
02/2021 - 06/2019
2Osteoporosis
02/2021 - 07/2020
1Immunoglobulin G4-Related Disease
09/2022
1Lymphadenopathy
08/2022
1Atrophy
04/2022
1Neoplasms (Cancer)
03/2022
1Body Weight (Weight, Body)
01/2022
1Interstitial Lung Diseases (Interstitial Lung Disease)
01/2022
1Fatigue
01/2022
1Inflammation (Inflammations)
08/2021
1Gastritis
07/2021
1Metaplasia
07/2021
1Low Back Pain (Lumbago)
01/2021
1Pituitary Neoplasms (Pituitary Adenoma)
01/2021
1Hematoma
11/2020
1Hemorrhage
11/2020
1Mediastinitis
11/2020
1Postmenopausal Osteoporosis
07/2020
1Disseminated Intravascular Coagulation
12/2019
1Leukemia
12/2019
1Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
12/2019
1Enthesopathy
06/2019
1Synovitis
06/2019
1Femoral Neck Fractures
08/2014
1Cysts
07/2014
1Lymphocele
01/2013
1Chylous Ascites
01/2013
1Ductal Carcinoma
01/2012

Drug/Important Bio-Agent (IBA)

4DenosumabFDA Link
01/2022 - 07/2020
3AntibodiesIBA
04/2022 - 02/2021
2GastrinsIBA
04/2022 - 03/2022
2Diphosphonates (Bisphosphonates)IBA
02/2021 - 07/2020
2Buthionine SulfoximineIBA
07/2011 - 11/2008
2diethyl maleateIBA
07/2011 - 11/2008
1Immunoglobulin G (IgG)IBA
09/2022
1COVID-19 VaccinesIBA
08/2022
1Intrinsic FactorFDA Link
04/2022
1Vitamin B 12 (Cyanocobalamin)FDA LinkGeneric
04/2022
1alpha-DefensinsIBA
01/2022
1AlloysIBA
01/2022
1Pharmaceutical PreparationsIBA
08/2021
1spasmolytic polypeptideIBA
07/2021
1Trefoil FactorsIBA
07/2021
1Pepsinogen A (Pepsinogen)IBA
07/2021
1cyclic citrullinated peptideIBA
02/2021
1Anti-Citrullinated Protein AntibodiesIBA
02/2021
1Teriparatide (Parathar)FDA Link
01/2021
1Growth Hormone (Somatotropin)IBA
01/2021
1Anti-Bacterial Agents (Antibiotics)IBA
11/2020
1Vitamin DFDA LinkGeneric
07/2020
1GlucocorticoidsIBA
07/2020
1Dacarbazine (DIC)FDA LinkGeneric
12/2019
1fibrin fragment D (D-dimer)IBA
12/2019
1AntithrombinsIBA
12/2019
1Asparaginase (Elspar)FDA Link
12/2019
1Fibrinogen (Factor I)FDA Link
12/2019
1Hemostatics (Antihemorrhagics)IBA
12/2019
1CytokinesIBA
06/2019
1Interleukin-6 (Interleukin 6)IBA
06/2019
1Liposomes (Liposome)IBA
06/2019
1Indocyanine Green (Cardio-Green)FDA LinkGeneric
06/2019
1Phenobarbital (Luminal)FDA Link
01/2015
1Estrogen ReceptorsIBA
01/2015
1Contrast MediaIBA
01/2015
16- (3- propylthio- 1,2,5- thiadiazol- 4- yl)- 1- azabicyclo(3.2.1)octaneIBA
07/2014
1Ethiodized Oil (Ethiodol)FDA Link
01/2013
1Biological ProductsIBA
01/2012
1neurotrophin 4IBA
06/2009
1Brain-Derived Neurotrophic Factor (BDNF)IBA
06/2009
1Proteins (Proteins, Gene)FDA Link
08/2005
1AntigensIBA
08/2005

Therapy/Procedure

1Neoadjuvant Therapy
08/2021
1Aftercare (After-Treatment)
08/2021
1General Anesthesia
11/2020
1Therapeutics
12/2019
1Hemiarthroplasty
08/2014
1Nephrectomy
01/2013